New satellite-based network will enable a European telco to expand connectivity in Africa, and will serve to backup fibre

COLOGNE, Germany & LUXEMBOURG-Tuesday, October 31st 2017 [ AETOS Wire ]

(BUSINESS WIRE)--A major European telecom operator will bring connectivity to new areas across North and West Africa and enable contingency services during fibre outages using a satellite-based solution. The network is implemented by CETel, a German provider of global end-to-end communications solutions, in partnership with SES Networks, who will deliver C-band capacity on SES’s NSS-7 satellite.

The new highly-reliable and resilient network consists of several sites located in African countries, which are connected to the customer’s European backbone infrastructure via CETel’s teleport and managed Multiprotocol Label Switching (MPLS) Network.

“CETel and SES Networks have been partnering on various projects in the EMEA region f ... Read more »

MUNICH & DAR ES SALAAM, Tanzania-Thursday, October 26th 2017 [ AETOS Wire ]

(BUSINESS WIRE)--REDAVIA, a global market leader of cost-effective, reliable rental solar power for businesses and communities, commissioned two minigrids in Isenzanya and Shitunguru, located in the Songwe region in western Tanzania. The two pioneering containers were financed by InfraCo Africa (part of PIDG).

Previously, both villages didn’t have access to power - a common situation in Tanzania with low electrification rates, leading to the usage of diesel or kerosene for lighting and other energy needs. This lack of energy led to delayed local development for residential applications (e.g. lights, TV), public services (e.g. education, healthcare), service businesses (e.g. shops, restaurants) and productive businesses (e.g. welding, crops processing).

“Electricity gives women like me opportunities to make a contribution to the development of our communities,” sa ... Read more »

 

SAN JOSE, Calif-Thursday, October 26th 2017 [ AETOS Wire ]

(BUSINESS WIRE) --Edgewater Networks, Inc., the leader in Network Edge Orchestration, in partnership with Polycom, Inc., a technology innovator for effective and productive communications and collaborations across geographically dispersed workforces, have completed interoperability testing of the Two-Way Active Measurement Protocol (TWAMP) and will now offer it as part of the Network Edge Orchestration platform and Unified Communications (UC) Endpoint software, respectively.

As part of the UC Multi-Level Intelligence Solution announced earlier this year, the UC Analytics enhancement measures round-trip network performance between any two devices that support the TWAMP protocol. TWAMP equips service providers with actionable intelligence through key performance indicators such as jitter, latency, and packet loss. By adding time stamps to endpoint measurements, greater accuracy and accounting for ... Read more »

Ozanimod demonstrated superiority versus interferon beta-1a (Avonex®) in reducing annualized relapse rates and MRI brain lesions at two years

Incidence of adverse events and serious adverse events similar to Avonex

Safety and tolerability profile consistent with prior phase II and III studies

Global registrations on track to begin by end of 2017

 

SUMMIT, N.J.-Monday, October 30th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today announced detailed results from the phase III RADIANCE™ Part B trial evaluating the efficacy and safety of ozanimod, a novel, oral, selective sphingosine 1-phosphate 1 (S1PR1) and 5 (S1PR5) receptor modulator, versus a first-line treatment, Avonex® (interferon beta-1a) (IFN), in patients with relapsing multiple sclerosis (RMS). The results were presented at MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting, which was held in Paris, October 25-28, 2017. ... Read more »

 Ozanimod demonstrated superiority versus interferon beta-1a (Avonex®) in reducing annualized relapse rates and MRI brain lesions

Incidence of adverse events and serious adverse events similar to Avonex

Safety and tolerability profile consistent with prior phase II studies

 

SUMMIT, N.J.-Monday, October 30th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today announced detailed results from the phase III SUNBEAM™ trial evaluating the efficacy and safety of ozanimod, a novel, oral, selective sphingosine 1-phosphate 1 (S1PR1) and 5 (S1PR5) receptor modulator, versus a first-line treatment, Avonex® (interferon beta-1a) (IFN), in patients with relapsing multiple sclerosis (RMS). The results were presented at the MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting, which is being held in Paris, October 25-28, 2017.

“People living with relapsing multiple sclerosis are still in ... Read more »

NEW YORK -Monday, October 30th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- The following is being released by Susman Godfrey LLP and Hausfeld LLP.

There is a Settlement with Citibank, N.A. and Citigroup Inc. (“Citibank”) that impacts individuals and institutions that entered into over-the-counter financial derivative and non-derivative instruments directly with Citibank, Barclays, or a Non-Settling Defendant that received payments tied to U.S. Dollar LIBOR. Citibank, Barclays, and the Non-Settling Defendants (Credit Suisse, Bank of America, JPMorgan, HSBC, Lloyds, WestLB, UBS, RBS, Deutsche Bank, Rabobank, Norinchukin, Bank of Tokyo-Mitsubishi UFJ, HBOS, SocGen, and RBC) are U.S. Dollar LIBOR Panel Banks. The instruments include certain interest rate swaps, forward rate agreements, asset swaps, collateralized debt obligations, credit default swaps, inflation swaps, total return swaps, options, and floating rate notes.

The litigation claims that the bank ... Read more »